Cite
HARVARD Citation
Flynn, R. et al. (2020). Ability of Primary Care Health Databases to Assess Medicinal Products Discussed by the European Union Pharmacovigilance Risk Assessment Committee. Clinical pharmacology & therapeutics. 107 (4), pp. 957-965. [Online].